Desktop Genetics

First-in-class CRISPR design and genome editing

Desktop Genetics was established in 2012 to help researchers discover and treat the root genetic causes of human disease. Today, Desktop Genetics is a recognised leader in genome editing technology, staffed by a dedicated team of genome editing experts, bioinformaticians and data scientists, driven by the real-world impact of CRISPR technology.

We have invested four years developing our core technology, DESKGEN AI, trained on the largest database of genome editing data in the world. DESKGEN AI powers our flagship DESKGEN CRISPR Library product range, which enables the work of our pharma, biotech and academic customers working in drug discovery, functional genomics and cell therapy.

Desktop Genetics' tools and technologies are used by over 1800 organisations all over the world, and our projects contribute directly to several key partnerships to bring CRISPR into the clinic.

As a biochemist turned software engineer, Riley recognized the enormous untapped potential for software innovation in the life sciences. An alum of Genentech, he brings ten years of laboratory-based genetic engineering experience to Desktop Genetics. Riley is passionate about developing the next generation of bioinformatics tools that drive science forward. He holds a Bachelor's of Engineering from Dartmouth College, a Bachelor’s of Arts in Biochemistry from Colby College and an MPhil in Bioscience Enterprise from the University of Cambridge.
A former chemical engineer keen on seeing personalized treatment realized, Victor has spent the past five years leading Desktop Genetics’ business development and CRISPR genome editing initiatives. He has closed several partnerships with leading life science companies placing Desktop Genetics at the forefront of CRISPR therapeutics research. Informed by his previous experience at P&G, GlaxoSmithKline and Flagship Ventures, Victor believes that software will be the key to unlocking the full potential of biotech R&D. He holds an MEng in Chemical Engineering from Imperial College London and an MPhil in Bioscience Enterprise from the University of Cambridge.
Edward has expertise in genome editing, synthetic biology, product development and marketing. He currently heads the marketing team at Desktop Genetics. In 2017 he was listed on the Forbes 30 Under 30 in Tech in Europe and nominated to the Kairos 50. Edward previously worked at the European Union, VERTIC and Kymab. Edward is a SynBio LEAP fellow, formerly co-chaired the iGEM software track, and was the UK Ambassador for Hello Tomorrow. Edward holds a BSc in Bioveterinary Science from London’s Royal Veterinary College and an MPhil in Bioscience Enterprise from the University of Cambridge.
Darrin is a scientist with a track record of securing over $275 million business financing as well as closing over $450 million of product, service, license and M&A deals. In 2012, he was named Business Leader of the Year at the European Life Science Awards; in 2014 he was named Executive of the Year by Scrip; and in 2015 was named UK Quoted Company Entrepreneur of the Year and Cambridge Business Person of the Year. Darrin holds a PhD in Biotechnology from the University of Cambridge. In 2014, Darrin listed Horizon Discovery Group plc on the AIM market of the London Stock Exchange achieving a placement of $113 million, an all-time record for a life science company on AIM and the largest ever from the Cambridge technology cluster.Darrin supports programs in the UK via the Professor Christopher R Lowe Carpe Diem Enterprise Fund and is an Entrepreneur in Residence at the Judge Business School and Enterprise Fellow at the Department of Chemical Engineering and Institute of Biotechnology. He is currently Chairman and co-founder of GeoSpock Ltd, Chairman of Desktop Genetics Ltd, Non-Executive Director of Cell Therapy Ltd and serves on the advisory boards of HealX3 Ltd, SimPrints Ltd, Cambridge Ahead, the Cambridge Phenomenon, the Cambridge Science Centre and Biotech and Money.
Jonathan, co-Founder and currently Deputy Chairman of Abcam plc, is an experienced entrepreneur and investor and is passionate about supporting UK life science and high-tech start-ups. He has provided considerable investment and support to over 30 companies and has assisted three technology companies to IPO on the London AIM Stock exchange. Jonathan gained his doctorate in Molecular Genetics at Leicester University after graduating in Applied Biology at Bath. From 1992–95, he was a postdoctoral researcher at Bath, following which he worked at the University of Cambridge in the lab of Professor Tony Kouzarides researching the molecular basis of breast cancer. He identified the market opportunity for supplying high-quality antibodies to support protein interaction studies, and in 1998, founded Abcam with David Cleevely and Professor Tony Kouzarides. Jonathan is currently Deputy Chairman and Founder of Abcam and a non-executive director of Horizon Discovery, Frontier Developments, Syndicate Room and GeoSpock. He is also Chairman of Axol Bioscience, Cambridge Allergy Therapy and PhoreMost and sits on the advisory boards of Desktop Genetics, Repositive, HealX and Definigen.
Hitesh is a Partner of Syncona Investment Management Ltd. He is an experienced investor in the sector, having spent over 20 years investing in public global equities in the life sciences, technology and the innovation sectors. He has worked at various institutions in equity research and Fund Management from ADIA, the sovereign wealth Fund of Abu Dhabi, JP Morgan, Aviva Group, Dresdner Bank and New Star Asset Management. He has a strong track record, rated AA manager and was also a top 1 percentile manager in global equities. He is on the Board of Desktop Genetics, a CRISPR IP library company, backed by Illumina and is an angel investor in early stage Innovation companies. He is also on the Investment Committee of the LBA Scale Up Innovation Fund. Hitesh holds a degree in Chemistry from Kings College, London, MBA from Cranfield University and CFA, the American Association of Investment Analysts.


Desktop Genetics is always on the lookout for talented people. Email us at